Celcuity Inc.
CELC
Rank in Stocks
#4261
Celcuity, Inc. operates as a cellular analysis company. The company discovers... Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Share Price
$70.37
Last synced: 2026-11-09
Market Cap
$3.44B
Change (1 day)
5.36%
Change (1 year)
-11.12%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Celcuity Inc. (CELC)
Category
Healthcare
EPS for Celcuity Inc. (CELC)
EPS as of September 2026 TTM: $-4.70
According to Celcuity Inc.'s latest financial reports, its current EPS (TTM) is $-4.70. At the end of 2025 the company had an EPS of $-3.79, a decrease compared to its 2024 EPS of $-2.83.
EPS history for Celcuity Inc. from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-4.70 | 24.01% |
| 2025 | $-3.79 | 33.92% |
| 2024 | $-2.83 | 5.20% |
| 2023 | $-2.69 | 0.37% |
| 2022 | $-2.68 | 17.54% |
| 2021 | $-2.28 | 156.18% |
| 2020 | $-0.89 | 28.99% |
| 2019 | $-0.69 | -6.76% |
| 2018 | $-0.74 | -11.90% |
| 2017 | $-0.84 | 71.43% |
| 2016 | $-0.49 | 36.11% |
| 2015 | $-0.36 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -433.19% |
US
|
|
| $-7.07 | 50.43% |
US
|
|
| $-5.29 | 12.55% |
AU
|
|
| $12.88 | -374.04% |
BE
|
|
| $21.56 | -558.72% |
NL
|
Questions about Celcuity Inc.'s earnings per share (EPS)
What is Celcuity Inc.'s earnings per share (EPS)?
Celcuity Inc.'s earnings per share (EPS) over the last twelve months is $-4.70, as of Sep 2026.
What was Celcuity Inc.'s earnings per share (EPS) in 2025?
In 2025, Celcuity Inc.'s earnings per share (EPS) was $-3.79, compared with $-2.83 in 2024.
How has Celcuity Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Celcuity Inc.'s earnings per share (EPS) was highest in 2020 ($-0.89) and lowest in 2025 ($-3.79).
How does Celcuity Inc.'s earnings per share (EPS) compare with similar companies?
Celcuity Inc.'s earnings per share (EPS) ($-4.70) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.